ici 204,219 has been researched along with montelukast in 89 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 21 (23.60) | 18.2507 |
| 2000's | 47 (52.81) | 29.6817 |
| 2010's | 16 (17.98) | 24.3611 |
| 2020's | 5 (5.62) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, CD; Summers, JB | 1 |
| Gelens, E; Nederkoorn, PH; Schoenmakers, SH; Timmerman, H; Zhang, MQ; Zwaagstra, ME | 1 |
| Abramovitz, M; Austin, CP; Bai, C; Caskey, CT; Chateauneuf, A; Connolly, BM; Coulombe, N; Evans, JF; Figueroa, DJ; Ford-Hutchinson, AW; Greig, GM; Hooks, SB; Hosfield, E; Im, DS; Kargman, S; Liu, Q; Lynch, KR; Metters, KM; O'Neill, GP; Sawyer, N; Stocco, R; Williams, DL; Zeng, Z | 1 |
| Ames, RS; Bergsma, DJ; Buckley, PT; Chambers, J; Dytko, GM; Ellis, C; Elshourbagy, N; Foley, JJ; Halsey, W; Hay, DW; Herrity, NC; Jenkins, O; Muccitelli, RM; Muir, AI; Murdock, PR; Nuthulaganti, P; Sarau, HM; Sathe, G; Schmidt, DB; Wilson, S | 1 |
| Capra, V; Nicosia, S; Panigalli, T; Ravasi, S; Rovati, GE | 1 |
| Anton, P; Bonjoch, J; Diaba, F; Miralpeix, M; Pagès, L; Pérez, D; Puig, C; Soca, L; Vilella, D | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Aratani, Y; Egashira, H; Fujita, M; Hisaichi, K; Ima, M; Imagawa, A; Inoue, A; Ishida, A; Itadani, S; Kadode, M; Kinoshita, A; Kitamine, T; Matsumura, N; Moriguchi, H; Nabe, T; Nakao, T; Nakayama, Y; Nomura, H; Ohmoto, K; Ohta, N; Sekiguchi, T; Sekioka, T; Tajima, Y; Takahashi, S; Takeuchi, J; Ueda, J; Yamaura, Y; Yashiro, K; Yonetomi, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Tan, RA | 1 |
| Anderson, GP; Ball, HA; Beck, A; Bittiger, H; Bray, MA; Felner, A; Gentsch, C; Gerspacher, M; Giese, K; Hauser, K; Kraetz, J; Niederhauser, U; Subramanian, N; Vassout, A; von Sprecher, A | 1 |
| Aharony, D | 1 |
| Bernstein, PR | 1 |
| Lane, SJ | 1 |
| Lipworth, BJ | 2 |
| Rosenwasser, LJ | 1 |
| Wedekind, CA | 1 |
| Anderson, P | 1 |
| Drazen, JM; Pauwels, R; Wechsler, ME | 1 |
| Bensch, G; Borish, L | 1 |
| Thien, FC | 1 |
| Kuna, P; Kupczyk, M | 1 |
| Chapman, KR; D'Urzo, AD | 1 |
| Stey, C | 1 |
| Burstein-Stein, J; Grieco, AJ | 1 |
| Corless, JA; Warburton, CJ | 1 |
| Stempel, DA; Stoloff, S | 1 |
| Dempsey, OJ | 1 |
| Bisgaard, H | 1 |
| Krawiec, ME; Wenzel, SE | 1 |
| García-Marcos, L; Schuster, A | 1 |
| Asero, R; Lorini, M; Tedeschi, A | 1 |
| Spector, SL | 1 |
| Ernst, ME; Maynard, ML | 1 |
| Adachi, M; Minoguchi, K | 1 |
| Hayden, ML | 1 |
| Hendeles, L; Segal, R | 1 |
| Davis, EA; Pathak, DS; Stanford, RH | 1 |
| Janson, S; Lazarus, SC | 1 |
| Martínez González, A; Mendia, JL; Naberan Toña, KX | 1 |
| Fowler, SJ; Hall, IP; Lipworth, BJ; Wheatley, AP; Wilson, AM | 1 |
| Kulus, M | 1 |
| Capella, GL | 1 |
| Valacer, DJ | 1 |
| Bacci, E; Dente, FL; Di Franco, A; Giannini, D; Paggiaro, PL; Taccola, M; Tonelli, M; Vagaggini, B; Zingoni, M | 1 |
| Andersen, L; Bouchelouche, K; Bouchelouche, P; Horn, T; Nordling, J | 1 |
| Keogh, KA; Specks, U | 1 |
| Dupré, DJ; Gingras, D; Le Gouill, C; Rola-Pleszczynski, M; Stanková, J | 1 |
| Paller, AS; Silverberg, NB | 1 |
| Kulkarni, SK; Patil, CS; Singh, VP | 1 |
| Sveum, RJ | 1 |
| Groneberg, DA; Schmidt, R; Staats, P; Wagner, U | 1 |
| Backman, JT; Jaakkola, T; Neuvonen, M; Neuvonen, PJ; Niemi, M | 1 |
| Chen, CJ; Hua, YM; Hung, CH; Jong, YJ; Li, CY; Yang, KD | 1 |
| Hiyama, Y; Ishimura, M; Kataoka, S; Maeda, T; Suda, M | 1 |
| Koyabu, N; Kuwano, M; Murakami, H; Nakamura, T; Ohtani, H; Satoh, H; Sawada, Y; Tsujimoto, M; Uchiumi, T; Ushigome, F; Yamashita, F | 1 |
| Ludington, E; Mehra, P; Simon, RA; Stevenson, DD; White, A | 1 |
| Dickerson, KS; Luttermoser, GK; Scow, DT | 1 |
| Bakhireva, LN; Chambers, CD; Johnson, D; Jones, KL; Klonoff-Cohen, HS; Schatz, M; Slymen, DJ | 1 |
| Guillevin, L; Guilpain, P; Lhote, F; Mouthon, L; Pagnoux, C | 1 |
| Culp, JA; Steinke, JW | 1 |
| Chohnabayashi, N; Nishimura, N; Sugiura, R | 1 |
| Chang, BS; Chang, JC; Huang, SC; Wang, YS | 1 |
| Drakatos, P; Karkoulias, K; Lykouras, D; Sampsonas, F; Spiropoulos, K | 1 |
| Chakravarty, G; Honer Zu Bentrup, K; Mondal, D; Roy, U | 1 |
| Alsaaty, S; Chen, LY; Nagineni, S; Shelhamer, JH; Woszczek, G | 1 |
| Calogiuri, G; D'Erasmo, M; Di Leo, E; Ferrannini, A; Montinaro, V; Nettis, E; Vacca, A | 1 |
| Gibbons, RD; Joo, MJ; Lee, TA; Schumock, GT; Stayner, LT; Valuck, RJ | 1 |
| Cui, Y; Du, C; Lv, J; Wang, L; Wei, W; Xie, X | 1 |
| Hamatsu, Y; Kataoka, M; Masaoka, Y; Sakuma, S; Yamashita, S; Yano, K | 1 |
| Anderson, R; Feldman, C; Gravett, CM; Steel, HC; Theron, AJ; Tintinger, GR | 1 |
| Krueaprasertkul, K; Sibmooh, N; Srihirun, S; Suknuntha, K; Vivithanaporn, P; Yubolphan, R | 1 |
| Chaithirayanon, K; Chongthammakun, S; Parakaw, T; Phuagkhaopong, S; Piromkraipak, P; Srihirun, S; Vivithanaporn, P | 1 |
| Liu, J; Tian, J; Wang, Y | 1 |
| Al-Azzam, N; Elsalem, L | 1 |
| Citron, F; Deem, AK; Genovese, G; Perelli, L; Viale, A | 1 |
| Aigner, L; Brunner, SM; Koller, A; Ladek, AM; Preishuber-Pflügl, J; Reitsamer, H; Runge, C; Trost, A | 1 |
| Bresnick, SD | 1 |
36 review(s) available for ici 204,219 and montelukast
| Article | Year |
|---|---|
Modulators of leukotriene biosynthesis and receptor activation.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Carrier Proteins; Forecasting; Humans; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Molecular Structure; Receptors, Leukotriene | 1996 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The role of antileukotrienes in asthma management.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Chromones; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
Pharmacology of leukotriene receptor antagonists.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Cyclopropanes; Dicarboxylic Acids; Disease Models, Animal; Humans; In Vitro Techniques; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
Chemistry and structure--activity relationships of leukotriene receptor antagonists.
Topics: Acetates; Anti-Asthmatic Agents; Biological Availability; Chromones; Cyclopropanes; Indoles; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Phenylcarbamates; Quinolines; SRS-A; Structure-Activity Relationship; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
Leukotriene antagonism in asthma and rhinitis.
Topics: Acetates; Asthma; Bronchi; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotriene D4; Lipoxygenase Inhibitors; Membrane Proteins; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Rhinitis; Sinusitis; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
Leukotriene-receptor antagonists.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Administration Schedule; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Montelukast and zafirlukast in asthma.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Child; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
Leukotriene modifiers in chronic urticaria.
Topics: Acetates; Adolescent; Adult; Child; Chronic Disease; Cyclopropanes; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome; Urticaria | 1999 |
[The role of leukotrienes in inflammation and leukotriene inhibitors].
Topics: Acetates; Arachidonate 5-Lipoxygenase; Asthma; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Leukotriene-receptor antagonists. Role in asthma management.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Bronchial Spasm; Chronic Disease; Cyclopropanes; Double-Blind Method; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Respiratory Therapy; Sulfides; Sulfonamides; Time Factors; Tosyl Compounds | 2000 |
[Leukotriene antagonists--do they have a value?].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2000 |
Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis.
Topics: Acetates; Bronchiectasis; Clinical Trials as Topic; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Placebos; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2000 |
Leukotriene receptor antagonist therapy.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Chronic Disease; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2000 |
Leukotriene modifiers in pediatric asthma management.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Membrane Proteins; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2001 |
Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.
Topics: Acetates; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Asthma; Bronchoconstriction; Child; Clinical Trials as Topic; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Phenylcarbamates; Phosphodiesterase Inhibitors; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2001 |
Antileukotrienes in asthma: present situation.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Chromones; Clinical Trials as Topic; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2001 |
Leukotriene receptor antagonists in the treatment of allergic rhinitis.
Topics: Acetates; Adolescent; Adult; Aged; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Middle Aged; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Sulfides; Sulfonamides; Tosyl Compounds; United States | 2001 |
[Leukotriene modifiers].
Topics: Acetates; Asthma; Chromones; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Phenylcarbamates; Practice Guidelines as Topic; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2001 |
Leukotriene modifiers. Expanded role may be on horizon.
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Patient Compliance; Phenylcarbamates; Quinolines; Safety; Steroids; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2000 |
Where do leukotriene modifiers fit in asthma management?
Topics: Acetates; Asthma; Child; Churg-Strauss Syndrome; Cyclopropanes; Forced Expiratory Volume; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Phenylcarbamates; Quinolines; Severity of Illness Index; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
[Reflections on antileukotrienes].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
[Leukotriene antagonist drugs].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
New treatments for asthma: the role of leukotriene modifier agents.
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Asthma, Exercise-Induced; Cyclopropanes; Drug Evaluation; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 1999 |
Childhood asthma. Balancing efficacy and adherence for optimum management.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Humans; Indoles; Infant; Leukotriene Antagonists; Phenylcarbamates; Practice Guidelines as Topic; Quinolines; Severity of Illness Index; Sulfides; Sulfonamides; Tosyl Compounds | 2005 |
Leukotriene receptor antagonists--an update.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Asthma; Child; Child, Preschool; Cyclopropanes; Delayed-Action Preparations; Humans; Indoles; Infant; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2005 |
Leukotriene inhibitors in the treatment of allergy and asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Cyclopropanes; Dermatitis, Atopic; Humans; Hydroxyurea; Hypersensitivity; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Sulfonamides; Tosyl Compounds | 2007 |
[Antileukotrienes and Churg-Strauss syndrome].
Topics: Acetates; Adult; Anti-Asthmatic Agents; Antibodies, Antineutrophil Cytoplasmic; Asthma; Chromones; Churg-Strauss Syndrome; Cohort Studies; Cyclopropanes; Humans; Incidence; Indoles; Leukotriene Antagonists; Leukotrienes; Phenylcarbamates; Quinolines; Retrospective Studies; Sulfides; Sulfonamides; Tosyl Compounds | 2007 |
Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Arachidonate 5-Lipoxygenase; Asthma; Chromones; Cyclopropanes; Humans; Hypersensitivity; Indoles; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2007 |
[Adverse effects of leukotriene-antagonists].
Topics: Acetates; Anaphylaxis; Chemical and Drug Induced Liver Injury; Chromones; Cyclopropanes; Drug Interactions; Enzyme Inhibitors; Hematologic Diseases; Humans; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases, Interstitial; Membrane Proteins; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2007 |
Targeting leukotrienes for the treatment of COPD?
Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Arachidonate 5-Lipoxygenase; Bronchoconstriction; Capillary Permeability; Carrier Proteins; CD8-Positive T-Lymphocytes; Cell Movement; Chromones; Cyclopropanes; Eosinophils; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Membrane Proteins; Neutrophils; Phenylcarbamates; Pulmonary Disease, Chronic Obstructive; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2009 |
The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field.
Topics: Acetates; Animals; Cyclopropanes; Humans; Hypersensitivity; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Skin Diseases; Sulfides; Sulfonamides; Tosyl Compounds | 2010 |
Association between leukotriene-modifying agents and suicide: what is the evidence?
Topics: Acetates; Adverse Drug Reaction Reporting Systems; Cyclopropanes; Drug Labeling; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Suicide; Sulfides; Sulfonamides; Tosyl Compounds; United States; United States Food and Drug Administration | 2011 |
Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Acetates; Anti-Asthmatic Agents; Arachidonate 5-Lipoxygenase; Asthma; Chromones; Cyclopropanes; Gene Expression Regulation; Humans; Immunity, Innate; Immunologic Factors; Indoles; Leukotriene Antagonists; Monocytes; Neutrophils; NF-kappa B; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2014 |
Suppressive Effect of Leukotriene Antagonists on Capsular Contracture in Patients Who Underwent Breast Surgery with Prosthesis: A Meta-Analysis.
Topics: Acetates; Adolescent; Adult; Breast Implantation; Breast Implants; Cyclopropanes; Female; Humans; Implant Capsular Contracture; Indoles; Leukotriene Antagonists; Middle Aged; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Risk Factors; Sulfides; Sulfonamides; Tosyl Compounds; Young Adult | 2020 |
Leukotriene D
Topics: Acetates; Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Cysteine; Gene Expression; Humans; Hypersensitivity; Indoles; Inflammation Mediators; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2020 |
4 trial(s) available for ici 204,219 and montelukast
| Article | Year |
|---|---|
Short-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmatics.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Humans; Indoles; Leukotriene Antagonists; Lung Volume Measurements; Male; Middle Aged; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2003 |
Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone.
Topics: Acetates; Administration, Oral; Adult; Anti-Asthmatic Agents; Aryl Hydrocarbon Hydroxylases; Cyclopropanes; Cytochrome P-450 CYP2C8; Drug Administration Schedule; Drug Interactions; Female; Humans; Hypoglycemic Agents; Indoles; Male; Phenylcarbamates; Pioglitazone; Quinolines; Substrate Specificity; Sulfides; Sulfonamides; Thiazolidinediones; Tosyl Compounds | 2006 |
Effect of leukotriene modifier drugs on the safety of oral aspirin challenges.
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Asthmatic Agents; Aspirin; Asthma; Cyclopropanes; Desensitization, Immunologic; Drug Hypersensitivity; Female; Forced Expiratory Volume; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Middle Aged; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2006 |
Safety of leukotriene receptor antagonists in pregnancy.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Fetus; Humans; Indoles; Infant, Newborn; Leukotriene Antagonists; Phenylcarbamates; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinolines; Safety; Sulfides; Sulfonamides; Teratogens; Tosyl Compounds | 2007 |
49 other study(ies) available for ici 204,219 and montelukast
| Article | Year |
|---|---|
Development of a three-dimensional CysLT1 (LTD4) antagonist model with an incorporated amino acid residue from the receptor.
Topics: Arginine; Flavonoids; Leukotriene Antagonists; Membrane Proteins; Models, Molecular; Molecular Conformation; Quinolines; Receptors, Leukotriene | 1998 |
Characterization of the human cysteinyl leukotriene CysLT1 receptor.
Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Chromosome Mapping; Cloning, Molecular; COS Cells; Humans; Leukotriene Antagonists; Leukotriene D4; Lung; Macrophages, Alveolar; Membrane Proteins; Molecular Sequence Data; Muscle, Smooth; Receptors, Leukotriene; Tissue Distribution; Transfection; X Chromosome; Xenopus laevis | 1999 |
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.
Topics: Amino Acid Sequence; Base Sequence; Binding Sites; Biological Transport; Calcium; Cells, Cultured; Cloning, Molecular; Humans; Leukotriene D4; Membrane Proteins; Molecular Sequence Data; Pertussis Toxin; Receptors, Leukotriene; Signal Transduction; Virulence Factors, Bordetella | 1999 |
Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
Topics: Acetates; Anti-Asthmatic Agents; Binding, Competitive; Chromones; Cyclopropanes; Humans; Kinetics; Leukotriene Antagonists; Leukotriene C4; Leukotriene D4; Membrane Proteins; Quinolines; Receptors, Leukotriene; Sulfides | 2002 |
Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Carbolines; Chemistry, Pharmaceutical; Drug Design; Guinea Pigs; Humans; Inhibitory Concentration 50; Leukotriene Antagonists; Models, Chemical; Receptors, Leukotriene; Structure-Activity Relationship; Time Factors | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.
Topics: Animals; Asthma; Biological Availability; Butyrates; Dogs; Guinea Pigs; Humans; Indoles; Leukotriene Antagonists; Rats; Receptors, Leukotriene | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline type.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Bronchoconstriction; Cyclopropanes; Guinea Pigs; Indoles; Leukotriene Antagonists; Leukotriene D4; Lung; Molecular Structure; Muscle, Smooth; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1997 |
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bone Density; Bronchial Spasm; Bronchodilator Agents; Child; Child, Preschool; Choice Behavior; Cromolyn Sodium; Cyclopropanes; Exercise; Female; Growth; Humans; Hydroxyurea; Indoles; Infant, Newborn; Ipratropium; Lactation; Leukotriene Antagonists; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Tachycardia; Theophylline; Tosyl Compounds | 1999 |
The emerging role of leukotriene antagonists in asthma therapy.
Topics: Acetates; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Glucocorticoids; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 1999 |
Leukotriene modifiers: new drugs, old and new reactions.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Autoimmune Diseases; Chromones; Churg-Strauss Syndrome; Cyclopropanes; Drug Hypersensitivity; Eosinophilia; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Lupus Erythematosus, Systemic; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Th2 Cells; Tosyl Compounds | 1999 |
Leukotriene modifiers--a new treatment option for asthma.
Topics: Acetates; Anti-Asthmatic Agents; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 1999 |
Taking a look at new advances in asthma therapy.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Nebulizers and Vaporizers; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?
Topics: Acetates; Adrenal Cortex Hormones; Asthma; Chromones; Churg-Strauss Syndrome; Cyclopropanes; Eosinophils; Female; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Middle Aged; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Leukotriene receptor antagonist drugs for asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Spasm; Child; Cromolyn Sodium; Cyclopropanes; Exercise; Female; Growth Disorders; Humans; Hydroxyurea; Indoles; Ipratropium; Lactation; Leukotriene Antagonists; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Theophylline; Tosyl Compounds | 2000 |
The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).
Topics: Abnormalities, Drug-Induced; Acetates; Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Budesonide; Chlorpheniramine; Cyclopropanes; Ephedrine; Female; Histamine H1 Antagonists; Humans; Hydroxyurea; Hypersensitivity; Indoles; Ipratropium; Leukotriene Antagonists; Metaproterenol; Nasal Decongestants; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Terbutaline; Tosyl Compounds; Tripelennamine | 2000 |
Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction.
Topics: Acetates; Aged; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchodilator Agents; Chemical and Drug Induced Liver Injury; Cyclopropanes; Female; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Tosyl Compounds | 2000 |
Churg-Strauss syndrome: is there an association with leukotriene modifiers?
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2000 |
Leukotriene receptor antagonists in chronic urticaria.
Topics: Acetates; Adult; Aged; Chronic Disease; Cyclopropanes; Female; Follow-Up Studies; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Phenylcarbamates; Quinolines; Remission Induction; Severity of Illness Index; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome; Urticaria | 2001 |
Safety of antileukotriene agents in asthma management.
Topics: Acetates; Asthma; Churg-Strauss Syndrome; Clinical Trials as Topic; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2001 |
Pharmacoeconomic studies of asthma controller drugs: marketing gimmick or icing on the cake?
Topics: Acetates; Administration, Inhalation; Administration, Oral; Androstadienes; Anti-Inflammatory Agents; Asthma; Cohort Studies; Cyclopropanes; Economics, Pharmaceutical; Fluticasone; Humans; Indoles; Leukotriene Antagonists; Managed Care Programs; Marketing of Health Services; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child; Cohort Studies; Cyclopropanes; Female; Fluticasone; Humans; Indoles; Male; Managed Care Programs; Middle Aged; Phenylcarbamates; Quinolines; Retrospective Studies; Sulfides; Sulfonamides; Tosyl Compounds; United States | 2002 |
5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists.
Topics: Acetates; Adult; Arachidonate 5-Lipoxygenase; Asthma; Cyclopropanes; Forced Expiratory Volume; Genotype; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Polymorphism, Genetic; Quinolines; Retrospective Studies; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
Anti-leukotriene drugs in the prevention and treatment of hepatorenal syndrome.
Topics: Acetates; Arachidonic Acid; Cyclopropanes; Hepatorenal Syndrome; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Liver; Phenylcarbamates; Protein Structure, Tertiary; Quinolines; Sulfides; Sulfonamides; Thromboxanes; Tosyl Compounds | 2003 |
The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle.
Topics: Acetates; Calcium; Cells, Cultured; Cyclopropanes; Cysteine; Cytosol; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Indoles; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Membrane Proteins; Muscle Contraction; Muscle, Smooth; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sarcoplasmic Reticulum; Sulfides; Sulfonamides; Tosyl Compounds; Urinary Bladder | 2003 |
Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists.
Topics: Acetates; Adolescent; Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Asthma; Biopsy; Central Nervous System Diseases; Child; Churg-Strauss Syndrome; Cyclopropanes; Electromyography; Eosinophilic Granuloma; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Indoles; Leukotriene Antagonists; Male; Middle Aged; Minnesota; Peroxidase; Phenylcarbamates; Predictive Value of Tests; Quinolines; Statistics as Topic; Sulfides; Sulfonamides; Survival Analysis; Tosyl Compounds; Treatment Outcome | 2003 |
Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1.
Topics: Acetates; Animals; Chlorocebus aethiops; COS Cells; Cyclopropanes; GTP-Binding Proteins; Humans; Indoles; Leukotriene Antagonists; Membrane Proteins; Phenylcarbamates; Propionates; Quinolines; Radioligand Assay; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds; Transfection | 2004 |
Leukotriene receptor antagonists are ineffective for severe atopic dermatitis.
Topics: Acetates; Adolescent; Adult; Aged; Child; Child, Preschool; Cyclopropanes; Dermatitis, Atopic; Female; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2004 |
Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats.
Topics: Acetates; Acetic Acid; Analgesics; Animals; Capillary Permeability; Carrageenan; Cyclopropanes; Dose-Response Relationship, Drug; Female; Hindlimb; Hydroxyurea; Hyperalgesia; Indoles; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Mice; Pain; Pain Measurement; Phenylcarbamates; Quinolines; Rats; Rats, Wistar; Receptors, Leukotriene B4; Sulfides; Sulfonamides; Tosyl Compounds | 2005 |
The cysteinyl-leukotriene-1 receptor antagonist zafirlukast is a potent secretagogue in rat and human airways.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetates; Animals; Arachidonic Acid; Bronchi; Chromones; Cyclooxygenase Inhibitors; Cyclopropanes; Dose-Response Relationship, Drug; Humans; Ibuprofen; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Membrane Proteins; Morpholines; Phenylcarbamates; Phosphoinositide-3 Kinase Inhibitors; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds; Trachea | 2005 |
Effects of leukotriene receptor antagonists on monocyte chemotaxis, p38 and cytoplasmic calcium.
Topics: Acetates; Anti-Asthmatic Agents; Blotting, Western; Calcium; Cell Separation; Chemotaxis; Cyclopropanes; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Fetal Blood; Flow Cytometry; Humans; Indoles; Intracellular Fluid; Leukotriene Antagonists; Monocytes; p38 Mitogen-Activated Protein Kinases; Phenylcarbamates; Photometry; Pregnancy; Quinolines; Reference Values; Sulfides; Sulfonamides; Time Factors; Tosyl Compounds | 2006 |
Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Acetylcholine; Albuterol; Animals; Atropine; Benzoquinones; Carbachol; Chromones; Cyclopropanes; Dinoprost; Drug Evaluation, Preclinical; Guinea Pigs; Heptanoic Acids; Histamine; In Vitro Techniques; Indoles; Indomethacin; Ketanserin; Ketotifen; Leukotriene Antagonists; Leukotriene D4; Male; Muscle Contraction; Muscle, Smooth; Phenylcarbamates; Powders; Procaterol; Prostaglandin Antagonists; Prostaglandin D2; Quinolines; Receptors, Thromboxane A2, Prostaglandin H2; Serotonin; Substance P; Sulfides; Sulfonamides; Tosyl Compounds; Trachea; Tryptophan | 2006 |
Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4.
Topics: Acetates; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biological Transport; Biphenyl Compounds; Blotting, Western; Cell Line; Chromones; Cyclopropanes; Dose-Response Relationship, Drug; Estrone; Humans; Imidazoles; Indoles; Leukotriene Antagonists; Losartan; Molecular Structure; Organic Anion Transporters, Sodium-Independent; Phenylcarbamates; Quinolines; Structure-Activity Relationship; Sulfides; Sulfonamides; Tetrazoles; Tosyl Compounds; Transfection; Tritium; Valine; Valsartan | 2006 |
Cysteinyl leucotriene receptor type 1 mediates contraction in human and guinea-pig oesophagus.
Topics: Acetates; Animals; Atropine; Capsaicin; Carbachol; Cholinergic Agonists; Cyclopropanes; Esophagus; Guinea Pigs; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Male; Muscarinic Antagonists; Muscle Contraction; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sensory System Agents; Sodium Channel Blockers; SRS-A; Sulfides; Sulfonamides; Tetrodotoxin; Tosyl Compounds | 2008 |
Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Antineoplastic Agents, Phytogenic; Biological Transport; Cell Line; Chemotherapy, Adjuvant; Cyclopropanes; Dogs; Drug Resistance, Neoplasm; Drug Resistance, Viral; Fluoresceins; HIV Infections; HIV Protease Inhibitors; Indoles; Leukotriene Antagonists; Multidrug Resistance-Associated Proteins; Neoplasms; Paclitaxel; Phenylcarbamates; Propionates; Quinolines; Saquinavir; Sulfides; Sulfonamides; Time Factors; Tosyl Compounds | 2009 |
Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.
Topics: Acetates; Calcium; Calcium Signaling; Cell Line; Cell Migration Inhibition; Cells, Cultured; Chemotaxis, Leukocyte; Cyclopropanes; Humans; Indoles; Inflammation Mediators; Intracellular Fluid; Leukotriene Antagonists; Models, Immunological; Monocytes; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds; Uridine Diphosphate | 2010 |
Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Blood-Brain Barrier; Blotting, Western; Cell Separation; Cyclopropanes; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Fluorescent Antibody Technique; Indoles; Inflammation; Mice; Mice, Inbred C57BL; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Spinal Cord; Sulfides; Sulfonamides; Tosyl Compounds | 2011 |
Assessment of absorption potential of poorly water-soluble drugs by using the dissolution/permeation system.
Topics: Absorption; Acetates; Administration, Oral; Animals; Area Under Curve; Caco-2 Cells; Celecoxib; Chemistry, Pharmaceutical; Cyclopropanes; Humans; Indoles; Intestinal Absorption; Male; Permeability; Phenylcarbamates; Pyrazoles; Quinolines; Rats; Rats, Wistar; Solubility; Sulfides; Sulfonamides; Technology, Pharmaceutical; Tosyl Compounds; Water | 2013 |
Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells
Topics: Acetates; Apoptosis; Cell Cycle; Cell Proliferation; Cyclopropanes; Female; Humans; Indoles; Leukotriene Antagonists; Mitogens; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2018 |
Cysteinyl leukotriene receptor antagonists induce apoptosis and inhibit proliferation of human glioblastoma cells by downregulating B-cell lymphoma 2 and inducing cell cycle arrest.
Topics: Acetates; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclopropanes; Down-Regulation; G1 Phase; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Proto-Oncogene Proteins c-bcl-2; Quinolines; Resting Phase, Cell Cycle; Sulfides; Sulfonamides; Tosyl Compounds; Up-Regulation | 2018 |
Leukotrienes, a potential target for Covid-19.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Betacoronavirus; Coronavirus Infections; COVID-19; Cyclopropanes; Cytokine Release Syndrome; Humans; Hydroxyurea; Immunologic Factors; Indoles; Leukotrienes; Pandemics; Phenylcarbamates; Pneumonia, Viral; Quinolines; SARS-CoV-2; Severity of Illness Index; Sulfides; Sulfonamides; Tosyl Compounds | 2020 |
Chronobiological activity of cysteinyl leukotriene receptor 1 during basal and induced autophagy in the ARPE-19 retinal pigment epithelial cell line.
Topics: Acetates; Autophagy; Blotting, Western; Cell Line; Cell Survival; Chronobiology Phenomena; Cyclopropanes; Epithelial Cells; Humans; Indoles; Leukotriene Antagonists; Oxidative Stress; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Retinal Pigment Epithelium; Sulfides; Sulfonamides | 2021 |
Comparison of Cromolyn Sodium, Montelukast, and Zafirlukast Prophylaxis for Capsular Contracture.
Topics: Breast Implants; Contracture; Cromolyn Sodium; Humans; Implant Capsular Contracture | 2023 |